NCT06625203 2024-10-03
MOSAIC
OWKIN
Recruiting
Clinical Trials
4 trialsNCT04491721 2020-07-29
Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL
ChineseAMS
Enrolling by invitation
NCT04425824 2020-06-16
Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma
ChineseAMS
Phase 2 Unknown
NCT01156259 2010-07-02
30Gy Versus 40Gy Involved-field Radiotherapy for Localized Diffuse Large B Cell Lymphoma Achieving CR After Chemotherapy
ChineseAMS
Phase 3 Unknown